Pharmaceutical Training Course Calendar

Back to details

Training format

Topic

Our Pharmaceutical calendar for the next 12 months:

Live online Classroom 2024 2025
Jul Aug Sep Oct Nov Dec Jan Mar Mar Apr May Jun
A Practical Guide to Producing and Maintaining the PSMF Vigilance 5 10 23
A Practical Guide to Writing Risk Management Plans (RMPs) Vigilance 9 21 21
Advanced Pharmacovigilance Vigilance 18-20 9-13 24-26 24-26
Advanced Project Management in Clinical Research Clinical Research 4 9
Agile Leadership for Pharma and Biopharma Professionals in a hybrid world Leadership & Strategy 18-19 6-7 6-7
An Essential Overview of Medical Information Regulatory Affairs 29 14 14
An Essential Overview of Pharmacovigilance Vigilance 9-10 27 15
An Essential Overview of the Medical Device Industry Regulatory Affairs 8 14 14
An Essential Overview of the Pharmaceutical and Biotech Industries Regulatory Affairs 13 16 12
An Introduction to Human Factors for Pharmaceutical and Medical Device Professionals Regulatory Affairs 23 17 17
An Introduction to Pharmaceutical Packaging GxP 25-27 28-30 19-21
Best Practice for Writing Effective SOPs Regulatory Affairs 12 27 27
Best Practices for Supplier Qualification in Life Science GxP 7-8 27-28 27-28
Biosimilars Biopharma 1-2 30-31 21-22
Biotechnology for the Non-Biotechnologist Biopharma 25-27 2-6
CAPA (Corrective and Preventative Action) Regulatory Affairs 13 28 28
Chemistry, Manufacture and Control (CMC) - Regulatory Requirements for Biological Drug Products GxP 17-18 26-27
Cleaning Validation Best Practice in Pharmaceuticals GxP 5-6 8-9
Clinical Overview and Clinical Summary: Creating Effective Marketing Authorisation Application Regulatory Affairs 23-24 18-19
Clinical Quality Management Systems Clinical Research 19-20 23-24 22-23
Clinical Trial Monitoring Clinical Research 29-30 2-3 28-29
Clinical Trial Regulatory Requirements Clinical Research 16-17 20-21 8-9
Cognitive Testing in Clinical Drug Trials: Successful Test Selection and Integration Clinical Research 12 19 19
Cosmetovigilance Vigilance 14-15 19-20
Data Integrity Auditor Masterclass GxP 17-18 12-13
Data Integrity and Document Management GxP 6 7
Delivery of Biologics to the Nasal Cavity Biopharma 8
Development of Combination Products: Critical Interactions GxP 3-4 24-25
Drafting Commercial Contracts for the Pharmaceutical Industry Commercial Contracts 20-21
Drafting and Negotiating Clinical Trial Agreements Commercial Contracts 5
Drug Discovery: A Step-by-Step Introduction Medical Technology 23-24 23-24 8-9
EU Clinical Trial Regulation 536/2014: Overview and Implementation Experience Clinical Research 11-12 2-3
EU Pharmaceutical Regulations & Strategy Regulatory Affairs 14-15 9-10
EU Proposed Pharmaceutical Legislation Changes Regulatory Affairs 18 20 19
Effective Technical Writing & Editing Medical Writing 1 5
Effective Technology Transfer GxP 7-8 2-3
Effective Training Skills in the Pharma Industry Coaching & Mentoring 10-11 26-27
European Post Marketing Pharmacovigilance - Including the EMA/PRAC Deliberations and Brexit Implications Vigilance 4-8 3-7 3-7
GCP and Clinical Research Update - Hot Inspection Topics Clinical Research 22 14 14
GMP Principles in Vaccine Manufacturing GxP 14-15 16-17
Global Pharmaceutical Regulatory Affairs Summer School Regulatory Affairs 9-13
Good Distribution Practices of Pharmaceuticals and APIs GxP 21-22 17-18 17-18
ICH Q9(R1) Quality Risk Management (QRM) GxP 25 29 12
MBA Strategic Thinking for Pharma and Biopharma Professionals Leadership & Strategy 3-4 16-17
Managing Service Providers including CRO and CMOs oversight to comply with ICH GCP R3 Clinical Research 17-18 23-24
Metrics and Earned Value in Clinical Research Projects Clinical Research 25 5 5
Navigating China’s API Regulations: An Essential Guide to DMF Registration GxP 23
Navigating EU and FDA Regulations for Drug/Device and Device/Drug Combination Products Regulatory Affairs 17-18 21-22 19-20
New EU GMP Annex 1: Compliant Aseptic Operations GxP 26-28 11-13 11-13
Pharmaceutical Development of ATMPs GxP 14-15 17-18
Pharmaceutical Regulatory Affairs in Africa Regulatory Affairs 19-20 16-17
Pharmaceutical Regulatory Affairs in Asia Regulatory Affairs 9-11 11-13
Pharmaceutical Regulatory Affairs in China Regulatory Affairs 10-11 31-1 31-1 24-25
Pharmaceutical Regulatory Affairs in Latin America Regulatory Affairs 22 18
Pharmaceutical Regulatory Affairs in Russia and the Eurasian Union Regulatory Affairs 3-4 19-20
Pharmaceutical Regulatory Affairs in the Middle East Regulatory Affairs 9-10 23-24
Pharmacovigilance Vigilance 11-13
Pharmacovigilance Aspects of Licensing Agreements Vigilance 27-28 10 10
Pharmacovigilance QMS & Inspection Preparation Vigilance 26-27 20-21 19-20
Pharmacovigilance for Drug Safety, Regulatory Affairs and PV Auditors – Broadening your Knowledge Vigilance 30-2 29-31 7-9
Positive Persuading and Influencing Skills for Pharma Professionals Management 29-30 11-12 17-18 17-18
Practical Requirements of the Arab Pharmacovigilance Guidelines Vigilance 12-13
Process Validation with Qualification GxP 23-24 13-14 20-21
Project Management for Pharma Professionals Project Management 26-27 9-10 10-11 10-11
Regulatory Affairs for Support Staff Regulatory Affairs 24-25 27-28 12-13
Regulatory Strategies for Orphan Drugs Regulatory Affairs 8 23
Risk Management for Pharma and Biopharma Professionals Regulatory Affairs 8 6
Root Cause Analysis and Critical Thinking Management 25 13 13
Signal Detection and Regulatory Expectations Vigilance 12-15 17-18 17-18
Smart Packaging and Electronic Patient Information GxP 4-5 13 13
Stability Testing of Pharmaceuticals and Biopharmaceuticals GxP 11-12
Successful Medical Writing – from Protocol to CTD Medical Writing 27-29
The Common Technical Document GxP 25-26 11-12 11-12
The Common Technical Document (CTD) Submission in the MENA Region Regulatory Affairs 28 13 13
The FDA Drug Approval Process Regulatory Affairs 2-3 11-12
The Leadership and Management Summer School for Pharma Professionals Leadership & Strategy 29-2
The Pharma Mini MBA Leadership & Strategy 31-2 6-8 19-21 19-21
Thinking Outside of the GMP Box GxP 10-11 14-15 13-14
US FDA - Understanding Key Factors When Working with the FDA Biopharma 27 13 13
Understanding Active Pharmaceutical Ingredients (APIs) GxP 18-19 25-26 25-26
Understanding Computer System Validation (CSV) GxP 4-5 18-19 18-19
Understanding Pharmacovigilance Regulations in APAC Vigilance 8-9 16-17
Variations to Marketing Authorisations Regulatory Affairs 28-29 3-4
Working with Emotional Intelligence in the Pharmaceutical and Biopharma Industry Leadership & Strategy 14 30